BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

BLT.AX says CEO and Managing Director Dr Peter French Resigned, page-71

  1. J8
    14,609 Posts.
    lightbulb Created with Sketch. 840
    clock Created with Sketch.
    10/12/15
    14:53
    Post #: 16587644
    We are in the efficacy stage of this trial. There were enough shRNA delivered to induce a response. There hasn't been enough time to start cohort four without shortening cohort three.
    BLT Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban
right-arrow Created with Sketch.
NEWS Resolute Mining down 10% on first US$80M payment to Mali's government
right-arrow Created with Sketch.
NEWS Smallcap Radiopharm notches +12% jump on pancreatic cancer imaging win
right-arrow Created with Sketch.
NEWS 'Major potential': Nanocap Forrestania hits 222g/t gold rock chip at Bonnie Vale
right-arrow Created with Sketch.
NEWS Things finally 'looking different' for up-and-down Hot Stock tip Stockland
right-arrow Created with Sketch.
NEWS EQR looks to become 'preeminent Western tungsten producer' with key acquisition
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.